Intermediate Risk Differentiated Thyroid Cancer Patients clinical trials

Explore recruiting intermediate risk differentiated thyroid cancer patients clinical trials.

Recruiting intermediate risk differentiated thyroid cancer patients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intermediate Risk Differentiated Thyroid Cancer Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intermediate Risk Differentiated Thyroid Cancer Patients trials by city

Intermediate Risk Differentiated Thyroid Cancer Patients in Toronto Intermediate Risk Differentiated Thyroid Cancer Patients in Vancouver Intermediate Risk Differentiated Thyroid Cancer Patients in Montreal Intermediate Risk Differentiated Thyroid Cancer Patients in Calgary Intermediate Risk Differentiated Thyroid Cancer Patients in Edmonton Intermediate Risk Differentiated Thyroid Cancer Patients in Ottawa Intermediate Risk Differentiated Thyroid Cancer Patients in Winnipeg Intermediate Risk Differentiated Thyroid Cancer Patients in Quebec City Intermediate Risk Differentiated Thyroid Cancer Patients in Hamilton Intermediate Risk Differentiated Thyroid Cancer Patients in Kitchener Intermediate Risk Differentiated Thyroid Cancer Patients in London Intermediate Risk Differentiated Thyroid Cancer Patients in Halifax Intermediate Risk Differentiated Thyroid Cancer Patients in New York Intermediate Risk Differentiated Thyroid Cancer Patients in Los Angeles Intermediate Risk Differentiated Thyroid Cancer Patients in Chicago Intermediate Risk Differentiated Thyroid Cancer Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease